GO:1900148 negative regulation of Schwann cell migration: Regulatory Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900148 describes any process that stops, prevents, or reduces the frequency, rate, or extent of Schwann cell migration, a critical step in peripheral nerve regeneration.
• Schwann cell migration is negatively regulated by microRNAs such as miR-34a, miR-3075, miR-148b, miR-29a-3p, and miR-140/miR-200, which target specific mRNAs to inhibit migration.
• Key proteins controlling this process include CNTN2, PMP22, CALR, CUL1, and LIF, which modulate cytoskeletal dynamics and cell adhesion during nerve repair.
• Dysregulation of negative regulation of Schwann cell migration is linked to peripheral neuropathies, impaired nerve regeneration, and potentially tumor progression.
• Experimental models for studying this process include knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screening and bioinformatics analysis.
• Understanding GO:1900148 provides insights into molecular brakes on Schwann cell motility, offering therapeutic targets for nerve injury and demyelinating diseases.
Description
Schwann cells are the principal glial cells of the peripheral nervous system, essential for myelination, trophic support, and nerve regeneration after injury. Following peripheral nerve damage, Schwann cells dedifferentiate and migrate to form bands of Büngner, guiding regenerating axons. However, excessive or misdirected migration can impair repair, necessitating tight regulatory control. The Gene Ontology term GO:1900148, negative regulation of Schwann cell migration, captures the biological processes that restrain this motility. This article synthesizes current knowledge on the molecular players and mechanisms that inhibit Schwann cell migration, based on published literature. We highlight microRNAs, signaling proteins, and cytoskeletal regulators that act as brakes on migration, and discuss how their dysfunction contributes to peripheral neuropathies and other disorders. Researchers can leverage this information to design experiments using CRISPR-based models to dissect causal roles of specific genes in this process.
negative regulation of Schwann cell migration At A Glance
| GO ID | GO:1900148 |
|---|---|
| GO term | negative regulation of Schwann cell migration |
| Ontology | biological_process |
| Synonym | down regulation of Schwann cell migration, down-regulation of Schwann cell migration, downregulation of Schwann cell migration, inhibition of Schwann cell migration |
| Major function | Inhibition of Schwann cell motility during peripheral nerve development and regeneration |
| Related processes | Schwann cell proliferation, myelination, axon guidance, nerve regeneration |
| Key regulators | miR-34a, miR-3075, miR-148b, miR-29a-3p, miR-140, miR-200, CNTN2, PMP22, CALR, LIF |
| Disease relevance | Peripheral neuropathies, impaired nerve regeneration, potential tumor suppression |
What Is GO:1900148?
GO:1900148, negative regulation of Schwann cell migration, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of Schwann cell migration. This biological process encompasses molecular events that inhibit the directed movement of Schwann cells, including microRNA-mediated repression of target genes, protein-protein interactions that stabilize the cytoskeleton, and signaling pathways that counteract pro-migratory cues.
Why Is negative regulation of Schwann cell migration Important in Cell Biology?
Negative regulation of Schwann cell migration is crucial for proper peripheral nerve regeneration, as it prevents excessive or misdirected migration that could disrupt the formation of guidance tracks for regenerating axons. Dysregulation of this process has been implicated in delayed nerve repair and neuropathic conditions. Understanding the molecular mechanisms that inhibit Schwann cell migration can reveal therapeutic targets to enhance nerve regeneration or to suppress aberrant migration in tumors.
• Controls the timing and extent of Schwann cell migration during nerve regeneration.
• Prevents disorganized migration that could impair axon guidance.
• MicroRNAs such as miR-34a and miR-3075 act as negative regulators by targeting CNTN2.
• PMP22 and CALR are involved in negative regulation of migration, linking to demyelinating neuropathies.
• Leukemia inhibitory factor (LIF) regulates Schwann cell proliferation and migration, affecting nerve repair.
• Dysregulation may contribute to peripheral neuropathies and impaired regeneration.
• Provides potential targets for enhancing nerve regeneration after injury.
• Relevant to understanding tumor suppressor mechanisms in Schwann cell-derived tumors.
• Experimental models using CRISPR can dissect causal roles of specific genes.
• Bioinformatics and library screening can identify novel regulators of this process.
What Happens During negative regulation of Schwann cell migration?
MicroRNA-mediated repression of pro-migratory genes
In simple terms: Small RNA molecules bind to messenger RNAs and prevent them from producing proteins that promote cell movement.
Several microRNAs negatively regulate Schwann cell migration by targeting mRNAs encoding proteins that enhance motility. For example, miR-34a directly targets CNTN2 (contactin 2) to inhibit Schwann cell proliferation and migration. Similarly, miR-3075 targets Cntn2 to suppress migration. miR-148b inhibits cell proliferation and migration by regulating CALR (calreticulin), while another study shows miR-148b-3p promotes migration by targeting CAND1, indicating context-dependent effects. miR-29a-3p modulates PMP22 (peripheral myelin protein 22) to affect Schwann cell proliferation and migration during nerve regeneration. Additionally, miR-140 and miR-200 regulate migratory heterogeneity of location-specific Schwann cell populations. These microRNAs act as molecular brakes on migration by reducing the levels of pro-migratory proteins.
Protein-protein interactions stabilizing the cytoskeleton
In simple terms: Certain proteins interact with each other to make the cell's internal skeleton more rigid, preventing movement.
PMP22, a tetraspan membrane protein, is involved in negative regulation of Schwann cell migration; its dysregulation by miR-29a-3p affects migration during peripheral nerve regeneration. CALR, a calcium-binding chaperone, when targeted by miR-148b, leads to inhibited proliferation and migration, suggesting that CALR may normally promote migration and its repression reduces motility. CAND1, a regulator of cullin-RING ubiquitin ligases, is targeted by miR-148b-3p to promote migration, indicating that CAND1 may act as a negative regulator of migration. These proteins modulate cytoskeletal dynamics and adhesion, contributing to the inhibition of migration.
Signaling pathways that counteract pro-migratory cues
In simple terms: Chemical signals can activate pathways that tell the cell to stop moving.
Leukemia inhibitory factor (LIF) regulates Schwann cell proliferation and migration and affects peripheral nerve regeneration. LIF signaling may inhibit migration under certain conditions, although its role is complex. Cdc2-mediated phosphorylation is required for Schwann cell migration during peripheral nerve regeneration, but negative regulation may involve phosphatases that reverse this phosphorylation. The balance between pro- and anti-migratory signals determines the net migration rate.
Transcriptional and post-translational control
In simple terms: Cells can turn genes on or off, or modify proteins after they are made, to control movement.
Negative regulation of Schwann cell migration can occur at transcriptional and post-translational levels. For instance, miR-34a and miR-3075 are themselves regulated by upstream signals, and their expression levels determine the extent of CNTN2 repression. Post-translational modifications such as phosphorylation of Cdc2 regulate migration. Additionally, the heterogeneity of Schwann cell populations in different locations is influenced by miR-140 and miR-200, which may affect migratory capacity. These layers of control ensure precise regulation of migration during nerve regeneration.
Key Genes Involved in GO:1900148 negative regulation of Schwann cell migration
The following genes and proteins have been experimentally implicated in the negative regulation of Schwann cell migration, based on published studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CNTN2 | Cell adhesion molecule; target of miR-34a and miR-3075 | Knockdown inhibits migration; overexpression promotes migration |
| PMP22 | Peripheral myelin protein; regulated by miR-29a-3p | Dysregulation linked to demyelinating neuropathies; affects migration |
| CALR | Calcium-binding chaperone; target of miR-148b | Repression inhibits proliferation and migration |
| CAND1 | Cullin-associated NEDD8-dissociated protein 1; target of miR-148b-3p | Promotes migration when repressed; potential negative regulator |
| LIF | Leukemia inhibitory factor; cytokine | Regulates proliferation and migration; affects nerve regeneration |
| CDC2 | Cyclin-dependent kinase 1; involved in cell cycle | Phosphorylation required for migration; negative regulation may involve phosphatases |
| miR-34a | MicroRNA targeting CNTN2 | Inhibits proliferation and migration |
| miR-3075 | MicroRNA targeting Cntn2 | Inhibits migration |
| miR-148b | MicroRNA targeting CALR | Inhibits proliferation and migration |
| miR-148b-3p | MicroRNA targeting CAND1 | Promotes migration by repressing CAND1 |
| miR-29a-3p | MicroRNA targeting PMP22 | Modulates proliferation and migration |
| miR-140 | MicroRNA involved in migratory heterogeneity | Regulates location-specific Schwann cell migration |
| miR-200 | MicroRNA involved in migratory heterogeneity | Regulates location-specific Schwann cell migration |
| CUL1 | Cullin 1; component of ubiquitin ligase complex | Interacts with CAND1; potential role in migration |
| NEDD8 | Ubiquitin-like protein | Modifies cullins; affects CAND1 function |
| Rho GTPases | Regulators of actin cytoskeleton | Downstream effectors of migration inhibition (implied) |
| FAK | Focal adhesion kinase | Potential mediator of migration signals (implied) |
| Integrins | Cell adhesion receptors | Modulate Schwann cell migration (implied) |
How Is negative regulation of Schwann cell migration Regulated?
The negative regulation of Schwann cell migration is controlled by a network of microRNAs and signaling proteins. MicroRNAs such as miR-34a, miR-3075, miR-148b, miR-29a-3p, and miR-140/miR-200 are key regulators that repress pro-migratory targets. Their expression is dynamically regulated during nerve injury and regeneration. For example, miR-29a-3p levels inversely correlate with PMP22 during nerve regeneration, suggesting a feedback loop. LIF signaling can modulate migration, possibly through JAK/STAT pathways. Cdc2 phosphorylation is required for migration, and its dephosphorylation by phosphatases may contribute to negative regulation. Additionally, CAND1 and CUL1-mediated ubiquitination may target proteins involved in migration for degradation. These regulatory mechanisms ensure that Schwann cell migration is tightly controlled in space and time.
negative regulation of Schwann cell migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PMP22 | Charcot-Marie-Tooth disease type 1A; demyelinating neuropathy | Knockout or point-mutation in Schwann cells; overexpression of miR-29a-3p |
| CNTN2 | Peripheral nerve regeneration; tumor suppression | Knockout and overexpression in Schwann cell lines; miR-34a mimic |
| CALR | Neuropathy; cell migration defects | Knockout and overexpression; miR-148b mimic |
| LIF | Impaired nerve regeneration | Knockout mice; LIF supplementation |
| CAND1 | Migration regulation; potential cancer | Knockout and overexpression; miR-148b-3p inhibitor |
Peripheral neuropathies and nerve regeneration
Dysregulation of negative regulation of Schwann cell migration can impair peripheral nerve regeneration. For instance, altered expression of miR-29a-3p and PMP22 is associated with defective nerve repair. LIF, which regulates migration, affects peripheral nerve regeneration, and its dysregulation may contribute to neuropathic conditions. Understanding these mechanisms could lead to therapies that enhance nerve regeneration by modulating microRNA activity.
Charcot-Marie-Tooth disease and demyelinating neuropathies
PMP22 is a major culprit in Charcot-Marie-Tooth disease type 1A, a common inherited demyelinating neuropathy. miR-29a-3p-mediated regulation of PMP22 affects Schwann cell proliferation and migration, linking negative regulation of migration to disease pathology. Modulating this pathway might offer therapeutic benefits.
Schwann cell tumors and cancer
Schwann cell migration is also relevant to tumorigenesis, as aberrant migration can contribute to metastasis. MicroRNAs such as miR-34a and miR-3075, which inhibit migration by targeting CNTN2, may act as tumor suppressors in Schwann cell-derived tumors. Loss of these microRNAs could enhance migration and promote tumor progression.
From negative regulation of Schwann cell migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CNTN2 negatively regulate Schwann cell migration? | CNTN2 knockout and overexpression in primary Schwann cells or cell lines |
| What is the role of PMP22 in migration inhibition? | PMP22 knockout and point-mutation models; miR-29a-3p overexpression |
| How does CALR affect migration? | CALR knockout and overexpression; miR-148b mimic |
| Does LIF signaling inhibit migration? | LIF knockout mice; LIF receptor knockout; overexpression |
| What is the effect of CAND1 on migration? | CAND1 knockout and overexpression; miR-148b-3p inhibitor |
| Can CRISPR library screening identify novel regulators? | Genome-wide CRISPR knockout library in Schwann cells followed by migration assay |
How to Study the negative regulation of Schwann cell migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Number of cells migrating through a membrane | Assess effect of microRNA mimics on Schwann cell migration |
| Scratch wound healing | Rate of cell migration into a gap | Evaluate negative regulation by LIF or PMP22 |
| qRT-PCR | mRNA and microRNA levels | Quantify CNTN2, PMP22, CALR expression |
| Western blot | Protein expression and phosphorylation | Measure Cdc2 phosphorylation, CALR levels |
| CRISPR knockout | Gene function loss | Test causal role of candidate genes |
| CRISPR overexpression | Gene function gain | Assess if gene inhibits migration |
| Library screening | Identify novel regulators | Genome-wide CRISPR screen for migration inhibitors |
| Bioinformatics | Pathway and network analysis | Integrate omics data to find regulatory modules |
Migration assays
Transwell and scratch wound healing assays are standard for measuring Schwann cell migration. These can be combined with microRNA mimics or inhibitors to assess negative regulation.
Gene expression analysis
Quantitative RT-PCR and Western blotting are used to measure levels of microRNAs and target proteins such as CNTN2, PMP22, and CALR.
CRISPR-based functional genomics
CRISPR knockout, knock-in, and overexpression models enable causal testing of candidate genes. Library screening can identify novel negative regulators of migration.
Bioinformatics and pathway analysis
RNA-seq and proteomics data can be analyzed to identify pathways enriched in negative regulation of migration. MicroRNA target prediction tools help identify interactions.
How CRISPR Can Be Used to Study GO:1900148 negative regulation of Schwann cell migration
Knockout
CRISPR knockout of candidate genes such as CNTN2, PMP22, or CALR in Schwann cell lines or primary cells can determine whether they are required for negative regulation of migration. For example, knocking out CNTN2 would be expected to reduce migration if CNTN2 is pro-migratory, but if it is a target of negative regulation, knockout may increase migration.
Point Mutation
Introducing point mutations in genes like PMP22 or Cdc2 can mimic disease-associated variants or phospho-null mutants to dissect specific residues required for migration inhibition. This is particularly useful for understanding how post-translational modifications regulate migration.
Knock-in
Knock-in of tagged versions of proteins (e.g., GFP-CNTN2) allows live-cell imaging of protein localization during migration. Knock-in of microRNA target site mutations can validate direct regulation.
Overexpression
Overexpression of microRNAs such as miR-34a or miR-3075, or proteins like PMP22, can test their ability to inhibit migration. Conversely, overexpression of pro-migratory genes can overcome negative regulation.
How EDITGENE Supports negative regulation of Schwann cell migration Research
Researchers studying negative regulation of Schwann cell migration-related genes often need to determine whether a candidate gene is causally involved in inhibiting or promoting migration. EDITGENE provides comprehensive CRISPR-based services to accelerate this research, from knockout and point-mutation models to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of Schwann cell migration research.
Frequently Asked Questions About negative regulation of Schwann cell migration
What is GO:1900148?
GO:1900148 is the Gene Ontology term for negative regulation of Schwann cell migration, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of Schwann cell migration.
What genes are involved in negative regulation of Schwann cell migration?
Key genes include CNTN2, PMP22, CALR, CAND1, LIF, and microRNAs such as miR-34a, miR-3075, miR-148b, miR-29a-3p, miR-140, and miR-200.
How do microRNAs regulate Schwann cell migration?
MicroRNAs bind to target mRNAs and repress their translation, reducing levels of pro-migratory proteins. For example, miR-34a targets CNTN2 to inhibit migration.
What is the role of PMP22 in Schwann cell migration?
PMP22 is a myelin protein whose dysregulation by miR-29a-3p affects Schwann cell proliferation and migration during nerve regeneration.
How is Schwann cell migration negatively regulated during nerve regeneration?
Negative regulation involves microRNA-mediated repression, protein-protein interactions, and signaling pathways that counteract pro-migratory cues, ensuring proper timing of migration.
What diseases are associated with dysregulation of Schwann cell migration?
Peripheral neuropathies, Charcot-Marie-Tooth disease, and impaired nerve regeneration have been linked to altered regulation of Schwann cell migration.
What experimental models are used to study negative regulation of Schwann cell migration?
Common models include knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screening and bioinformatics analysis.
How can CRISPR be used to study negative regulation of Schwann cell migration?
CRISPR can create knockout, point-mutation, knock-in, and overexpression models to test the causal role of specific genes in migration inhibition.
What is the role of LIF in Schwann cell migration?
Leukemia inhibitory factor (LIF) regulates Schwann cell proliferation and migration and affects peripheral nerve regeneration.
What is the significance of Cdc2 in Schwann cell migration?
Cdc2-mediated phosphorylation is required for Schwann cell migration during peripheral nerve regeneration, and its negative regulation may involve dephosphorylation.
Conclusion
The negative regulation of Schwann cell migration (GO:1900148) is a finely tuned biological process essential for proper peripheral nerve regeneration. MicroRNAs and proteins such as CNTN2, PMP22, CALR, and LIF act as molecular brakes on migration, and their dysregulation contributes to neuropathies and impaired nerve repair. Continued research using CRISPR-based models and bioinformatics will uncover new regulators and therapeutic targets. EDITGENE offers comprehensive services to support these investigations, from knockout and point-mutation models to library screening and bioinformatics analysis.
References
- 1. Zou D et al.. 2020. MiR-34a regulates Schwann cell proliferation and migration by targeting CNTN2.. Neuroreport 31(17):1180-1188 PMID: 33044326
- 2. Chen Q et al.. 2023. miR-140 and miR-200 regulate the migratory heterogeneity of location-specific Schwann cell population.. J Neurochem 166(4):692-704 PMID: 37171465
- 3. Wang P et al.. 2018. miR-3075 Inhibited the Migration of Schwann Cells by Targeting Cntn2.. Neurochem Res 43(10):1879-1886 PMID: 30078168
- 4. Shen Y et al.. 2022. Dysregulated miR-29a-3p/PMP22 Modulates Schwann Cell Proliferation and Migration During Peripheral Nerve Regeneration.. Mol Neurobiol 59(2):1058-1072 PMID: 34837628
- 5. Han IS et al.. 2007. Cdc2-mediated Schwann cell migration during peripheral nerve regeneration.. J Cell Sci 120(Pt 2):246-55 PMID: 17200138
- 6. Zhou Z et al.. 2019. Mechanism of miR-148b inhibiting cell proliferation and migration of Schwann cells by regulating CALR.. Artif Cells Nanomed Biotechnol 47(1):1978-1983 PMID: 31174435
- 7. Chen Q et al.. 2021. Leukemia inhibitory factor regulates Schwann cell proliferation and migration and affects peripheral nerve regeneration.. Cell Death Dis 12(5):417 PMID: 33888681
- 8. Qian TM et al.. 2016. miR-148b-3p promotes migration of Schwann cells by targeting cullin-associated and neddylation-dissociated 1.. Neural Regen Res 11(6):1001-5 PMID: 27482232
